Activity

Activity ID

3616

Expires

October 22, 2022

Format Type

Enduring

CME Credit

0.5

Fee

$30

CME Provider: JAMA

Description of CME Course

Even though it gained notoriety for recreational uses, ketamine is experiencing a resurgence in clinical settings given its versatility and potential applications, including for pain treatment and depression. David Juurlink, MD, from Sunnybrook Health Sciences Center in Toronto, Canada, and John Krystal, MD, from Yale University in New Haven, Connecticut, discuss current and emerging applications of this drug.

Disclaimers
1. This activity is accredited by the American Medical Association.
2. This activity is free to AMA members.

Register for this Activity

ABMS Member Board Approvals by Type
More Information
Commercial Support?
No

NOTE: If a Member Board has not deemed this activity for MOC approval as an accredited CME activity, this activity may count toward an ABMS Member Board’s general CME requirement. Please refer directly to your Member Board’s MOC Part II Lifelong Learning and Self-Assessment Program Requirements.

Educational Objectives

To review the emerging uses of ketamine for analgesia in adults.

Keywords

Anesthesiology, Depressive Disorders, Psychiatry

Competencies

Medical Knowledge, Practice-based Learning & Improvement

CME Credit Type

AMA PRA Category 1 Credit

Practice Setting

Inpatient, Outpatient, Rural, Urban

View All Activities by this CME Provider

The information provided on this page is subject to change. Please refer to the CME Provider’s website to confirm the most current information.